


Programs
Aiming to treat β-thalassemia and sickle cell disease with gene-edited hematopoietic stem cells




Press Releases
Jun 15, 2021
Jun 11, 2021
May 25, 2021
CRISPR Therapeutics to Participate in Upcoming Investor Conferences


Join Our Team
We're looking for energetic, collaborative and talented people who like challenges, want to make a difference and have a track record of delivering results. View open opportunities


You are now leaving the CRISPR Therapeutics website.
CRISPR Therapeutics is not responsible for the content or availability of third-party sites.